Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2014
Reporting Period: Quarter ended June 30, 2014
Context: The filing announces financial results for the second quarter of 2014. The full details are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are located within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 28, 2014) for actual financial figures.
- Verify the specific revenue and net loss figures for the quarter ended June 30, 2014.
- Check the press release for updates on clinical trial progress or regulatory milestones, which are typical for this company.
- Confirm cash position and burn rate details from the full press release to assess liquidity runway.